The highly selective dopamine D3R antagonist, R-VK4-40 attenuates oxycodone reward and augments analgesia in rodents.
Jordan CJ, Humburg B, Rice M, Bi GH, You ZB, Shaik AB, Cao J, Bonifazi A, Gadiano A, Rais R, Slusher B, Newman AH, Xi ZX.
Jordan CJ, et al. Among authors: bi gh.
Neuropharmacology. 2019 Nov 1;158:107597. doi: 10.1016/j.neuropharm.2019.04.003. Epub 2019 Apr 8.
Neuropharmacology. 2019.
PMID: 30974107
Free PMC article.